Oncosec Medical Stock Current Valuation
ONCSDelisted Stock | USD 0.06 0 3.63% |
Valuation analysis of OncoSec Medical helps investors to measure OncoSec Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that OncoSec Medical's price fluctuation is very steady at this time. Calculation of the real value of OncoSec Medical is based on 3 months time horizon. Increasing OncoSec Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the OncoSec stock is determined by what a typical buyer is willing to pay for full or partial control of OncoSec Medical. Since OncoSec Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OncoSec Stock. However, OncoSec Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.0584 | Real 0.0555 | Hype 0.06 |
The intrinsic value of OncoSec Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence OncoSec Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of OncoSec Medical helps investors to forecast how OncoSec stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OncoSec Medical more accurately as focusing exclusively on OncoSec Medical's fundamentals will not take into account other important factors: OncoSec Medical Company Current Valuation Analysis
OncoSec Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current OncoSec Medical Current Valuation | 5.6 M |
Most of OncoSec Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OncoSec Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, OncoSec Medical has a Current Valuation of 5.6 M. This is 99.96% lower than that of the Biotechnology sector and 99.88% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.97% higher than that of the company.
OncoSec Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OncoSec Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OncoSec Medical could also be used in its relative valuation, which is a method of valuing OncoSec Medical by comparing valuation metrics of similar companies.OncoSec Medical is currently under evaluation in current valuation category among its peers.
OncoSec Fundamentals
Return On Equity | -4.1 | |||
Return On Asset | -0.93 | |||
Current Valuation | 5.6 M | |||
Shares Outstanding | 5.96 M | |||
Shares Owned By Insiders | 28.01 % | |||
Shares Owned By Institutions | 5.83 % | |||
Number Of Shares Shorted | 192.06 K | |||
Price To Earning | (3.12) X | |||
Price To Book | 0.78 X | |||
EBITDA | (35.92 M) | |||
Net Income | (34.18 M) | |||
Cash And Equivalents | 19.48 M | |||
Cash Per Share | 0.50 X | |||
Total Debt | 6.17 M | |||
Debt To Equity | 0.76 % | |||
Current Ratio | 4.51 X | |||
Book Value Per Share | (1.85) X | |||
Cash Flow From Operations | (32.14 M) | |||
Short Ratio | 0.34 X | |||
Earnings Per Share | (20.31) X | |||
Target Price | 110.0 | |||
Number Of Employees | 40 | |||
Beta | 2.0 | |||
Market Capitalization | 1.65 M | |||
Total Asset | 21.88 M | |||
Retained Earnings | (285.96 M) | |||
Working Capital | 8.6 M | |||
Current Asset | 29.42 M | |||
Current Liabilities | 3.47 M | |||
Z Score | -23.08 | |||
Net Asset | 21.88 M |
About OncoSec Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OncoSec Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OncoSec Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OncoSec Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |